Stockscreener 앱 받기
35.22
2.14%
-0.4812
전일 마감가:
$35.70
열려 있는:
$35.17
하루 거래량:
17,332
Relative Volume:
0.02
시가총액:
$5.50B
수익:
$5.29B
순이익/손실:
$191.46M
주가수익비율:
29.88
EPS:
1.1785
순현금흐름:
$298.82M
1주 성능:
+1.44%
1개월 성능:
-10.35%
6개월 성능:
+191.14%
1년 성능:
+191.38%
1일 변동 폭
$34.96
$35.56
1주일 범위
$33.29
$36.55
52주 변동 폭
$7.50
$43.08
Pacs Group Inc Stock (PACS) Company Profile
명칭
Pacs Group Inc
전화
(801) 447-9829
주소
90 S. 400 W. SUITE 700, SALT LAKE CITY
Compare PACS vs HCA, THC, FMS, ENSG, UHS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
35.01 | 5.51B | 5.29B | 191.46M | 298.82M | 1.1785 |
|
HCA
Hca Healthcare Inc
|
510.97 | 117.44B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
211.39 | 19.07B | 21.31B | 2.37B | 2.53B | 15.49 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.57 | 12.85B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
ENSG
Ensign Group Inc
|
209.96 | 12.17B | 5.06B | 344.26M | 370.71M | 5.8446 |
|
UHS
Universal Health Services Inc
|
195.32 | 11.82B | 17.36B | 1.51B | 849.25M | 23.15 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-17 | 재개 | JP Morgan | Overweight |
| 2024-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-06 | 재개 | JP Morgan | Overweight |
| 2024-10-09 | 개시 | UBS | Buy |
| 2024-09-11 | 재개 | Citigroup | Buy |
| 2024-06-28 | 개시 | Macquarie | Outperform |
| 2024-05-06 | 개시 | Citigroup | Buy |
| 2024-05-06 | 개시 | JP Morgan | Overweight |
| 2024-05-06 | 개시 | Oppenheimer | Outperform |
| 2024-05-06 | 개시 | RBC Capital Mkts | Outperform |
| 2024-05-06 | 개시 | Stephens | Overweight |
| 2024-05-06 | 개시 | Truist | Buy |
모두보기
Pacs Group Inc 주식(PACS)의 최신 뉴스
Momentum Shift: Can PACS Group Inc reach resistance levels soon2026 Earnings Surprises & Daily Profit Maximizing Tips - baoquankhu1.vn
Jergensen Joshua, president & COO of PACS Group, sells $1.24 million in stock - Investing.com
PACS: Record 2025 growth, strong financials, and robust M&A pipeline position the company for 2026 - TradingView
Zacks Industry Outlook Highlights BrightSpring Health Services, InnovAge and PACS - TradingView
PACS Group, Inc. (PACS) Stock Price, News, Quote & History - Yahoo! Finance Canada
PACS Group, Inc. to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 17, 2026 - The Joplin Globe
Annual Healthcare MedTech & Services Conference on March 17, 2026 - Business Wire
3 Medical Service Industry Stocks Set to Counter Workforce Issues - TradingView
PACS Group (PACS) price target increased by 17.62% to 36.89 - MSN
PACS Group adds former CMS official Patrick Conway to board By Investing.com - Investing.com Nigeria
A Look At PACS Group (PACS) Valuation After Record Earnings And Zacks Rank Upgrade - simplywall.st
Live PACS Group, Inc. (PACS) Technical Analysis - Traders Union
Technical Reactions to PACS Trends in Macro Strategies - Stock Traders Daily
PACS Group (PACS) Insider Trading Activity 2026 $PACS - MarketBeat
Does PACS Group’s (PACS) Optum CEO Board Addition Reframe Its Value-Based Care Ambitions? - Sahm
PACS Group Earnings Call Highlights Profitable, Disciplined Growth - The Globe and Mail
PACS vs. MEDP: Which stock is the better value option? - MSN
PACS Group, Inc. (PACS) Raised to Strong Buy: The Reasons Explained - Bitget
PACS Group, Inc. (PACS) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Does PACS Group, Inc. (PACS) have the potential to rally 25.45% as Wall Street analysts expect? - MSN
Is PACS Group (PACS) Pricing Reflect Its Recent Share Price Pullback And Growth Hopes - Yahoo Finance
Mark Hancock - Forbes
[144] PACS Group, Inc. SEC Filing - Stock Titan
PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-03-08 | PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PACS | Press Release - Stockhouse
Pacs (PACS) Hits 52-Week High on Q3 Blowout - MSN
PACS Group (NYSE:PACS) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
PACS Group, Inc. 8-K Filing: Company Information, Common Stock Trading Details, and SEC Compliance Disclosure (March 2026) - Minichart
PACS Group adds former CMS official Patrick Conway to board - Investing.com
PACS Group Appoints Patrick Conway to Board of Directors - TipRanks
Director at PACS Group (PACS) receives 3,497 restricted stock units grant - Stock Titan
Patrick Hugh Conway joins PACS Group (PACS) insider roster with Form 3 - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PACS vs. MEDP: Which Stock Is the Better Value Option? - Bitget
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors - 01net
Does PACS Group, Inc. (PACS) Have the Potential to Rally 25.45% as Wall Street Analysts Expect? - Finviz
PACS Group Appoints Dr. Patrick Conway to Board - National Today
Pacs Group, Inc. appoints Dr. Patrick Conway, MD, MSc to board of directors - marketscreener.com
Best Momentum Stock to Buy for March 5th - Yahoo Finance Australia
Best Value Stock to Buy for March 5th - Yahoo Finance
A Look At PACS Group (PACS) Valuation After Record 2025 Results And New 2026 Guidance - simplywall.st
5 Analysts Assess PACS Group: What You Need To Know - Benzinga
PACS Stock Receives Updated "Buy" Rating from UBS Today | PACS S - GuruFocus
PACS Group (NYSE:PACS) Price Target Raised to $44.00 at UBS Group - MarketBeat
UBS Adjusts PACS Group Price Target to $44 From $42, Maintains Buy Rating - marketscreener.com
PACS Group Inc (PACS) Shares Up 2.9% on Mar 4 - GuruFocus
Oppenheimer Adjusts Price Target on PACS Group to $42 From $40, Maintains Outperform Rating - marketscreener.com
PACS Group (NYSE:PACS) Price Target Raised to $42.00 at Oppenheimer - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating PACS Group, Inc. (PACS) And Encourages Shareholders to Connect - ACCESS Newswire
PACS Group (PACS) awards 30,000 restricted stock units to Chief Compliance Officer - Stock Titan
PACS Group (NASDAQ: PACS) awards 25,000 RSUs to HR chief - Stock Titan
Pacs Group Inc (PACS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.58%
0.76%
자본화:
|
볼륨(24시간):